Pemetrexed combined with dual immune checkpoint blockade enhances cytotoxic T lymphocytes against lung cancer

MC Chen, MY Hung, CM Pan, SW Huang… - Cancer …, 2023 - Wiley Online Library
Chemotherapy, in combination with immune checkpoint blockade (ICB) targeting to
programmed death‐1 (PD‐1) or its ligand PD‐L1, is one of the first‐line treatments for …

Pemetrexed combined with dual immune checkpoint blockade enhances cytotoxic T lymphocytes against lung cancer

MC Chen, H Meng-Yu, CM Pan, H Shi-Wei… - Cancer …, 2023 - search.proquest.com
Chemotherapy, in combination with immune checkpoint blockade (ICB) targeting to
programmed death-1 (PD-1) or its ligand PD-L1, is one of the first-line treatments for patients …

Pemetrexed combined with dual immune checkpoint blockade enhances cytotoxic T lymphocytes against lung cancer.

MC Chen, MY Hung, CM Pan, SW Huang, CI Jan… - Cancer …, 2023 - europepmc.org
Chemotherapy, in combination with immune checkpoint blockade (ICB) targeting to
programmed death‐1 (PD‐1) or its ligand PD‐L1, is one of the first‐line treatments for …

[HTML][HTML] Pemetrexed combined with dual immune checkpoint blockade enhances cytotoxic T lymphocytes against lung cancer

MC Chen, MY Hung, CM Pan, SW Huang, CI Jan… - Cancer …, 2023 - ncbi.nlm.nih.gov
Chemotherapy, in combination with immune checkpoint blockade (ICB) targeting to
programmed death‐1 (PD‐1) or its ligand PD‐L1, is one of the first‐line treatments for …

Pemetrexed combined with dual immune checkpoint blockade enhances cytotoxic T lymphocytes against lung cancer

MC Chen, MY Hung, CM Pan, SW Huang… - Cancer …, 2023 - pubmed.ncbi.nlm.nih.gov
Chemotherapy, in combination with immune checkpoint blockade (ICB) targeting to
programmed death-1 (PD-1) or its ligand PD-L1, is one of the first-line treatments for patients …

Pemetrexed combined with dual immune checkpoint blockade enhances cytotoxic T lymphocytes against lung cancer.

MC Chen, MY Hung, CM Pan, SW Huang, CI Jan… - Cancer …, 2023 - europepmc.org
Chemotherapy in combination with immune checkpoint blockade (ICB) targeting to
programmed death-1 (PD-1) or its ligand PD-L1 is one of the first-line treatments for patients …